Cairo – Mubasher: Minapharm Pharmaceuticals reported standalone net profits of EGP 225.63 million in the first nine months of 2021, up by 134.8% year-on-year (YoY) from EGP 96.09 million.
The net sales rose to EGP 1.59 billion in the January-September period, compared to EGP 1.18 billion in the year-ago period, according to a bourse disclosure on Thursday.
In the first half (H1) of 2021, the company's consolidated net profits attributable to the company's owners amounted to EGP 255.63 million, compared to EGP 130.11 million in H1-20.
Source: Mubasher
All Rights Reserved - Mubasher Info © 2005 - 2021 Provided by SyndiGate Media Inc. (Syndigate.info).
Disclaimer: The content of this article is syndicated or provided to this website from an external third party provider. We are not responsible for, and do not control, such external websites, entities, applications or media publishers. The body of the text is provided on an “as is” and “as available” basis and has not been edited in any way. Neither we nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this article. Read our full disclaimer policy here.
